Fatty acids and the endoplasmic reticulum in nonalcoholic fatty liver disease

BioFactors

Volumn 37, Issue 1, 2011, Pages 8-16

  Gentile, Christopher L ^a   Frye, Melinda A ^a   Pagliassotti, Michael J ^a  

^a Department of Ecosystem Science and Sustainability   (United States)

Author keywords

ER stress; Liver injury; NAFLD; Saturated fatty acids

Indexed keywords

LIPID; SATURATED FATTY ACID;

ARTICLE; CELL DEATH; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; HUMAN; LIVER CELL; LIVER DYSFUNCTION; NONALCOHOLIC FATTY LIVER; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; UNFOLDED PROTEIN RESPONSE;

ANIMALS; APOPTOSIS; ENDOPLASMIC RETICULUM; FATTY ACIDS; FATTY LIVER; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; STRESS, PHYSIOLOGICAL; UNFOLDED PROTEIN RESPONSE;

EID: 79951600838     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.135     Document Type: Article

References (151)

1. Festi, D., Colecchia, A., Sacco, T., Bondi, M., Roda, E., and Marchesini, G. ( 2004) Hepatic steatosis in obese patients: clinical aspects and prognostic significance. Obes. Rev. 5, 27-42.
2. Lewis, J. R. and Mohanty, S. R. ( 2010) Nonalcoholic fatty liver disease: a review and update. Dig. Dis. Sci. 55, 560-578.
3. Szczepaniak, L. S., Victor, R. G., Orci, L., and Unger, R. H. ( 2007) Forgotten but not gone: the rediscovery of fatty heart, the most common unrecognized disease in America. Circ. Res. 101, 759-767.
4. Wieckowska, A., McCullough, A. J., and Feldstein, A. E. ( 2007) Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future. Hepatology 46, 582-589.
5. Neuschwander-Tetri, B. A. and Caldwell, S. H. ( 2003) Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology 37, 1202-1219.
6. Tiniakos, D. G., Vos, M. B., and Brunt, E. M. ( 2010) Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu. Rev. Pathol. 5, 145-171.
7. Powell, E. E., Cooksley, W. G., Hanson, R., Searle, J., Halliday, J. W., Powell, L. W. ( 1990) The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 11, 74-80.
8. Bacon, B. R., Farahvash, M. J., Janney, C. G., and Neuschwander-Tetri, B. A. ( 1994) Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 107, 1103-1109.
9. Clark, J. M. and Diehl, A. M. ( 2003) Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis. JAMA 289, 3000-3004.
10. Targher, G., Bertolini, L., Poli, F., Rodella, S., Scala, L., Tessari, R., Zenari, L., and Falezza G. ( 2005) Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes 54, 3541-3546.
11. Soderberg, C., Stal, P., Askling, J., Glaumann, H., Lindberg, G., Marmur, J., and Hultcrantz R. ( 2010) Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology 51, 595-602.
12. Targher, G., Day, C. P., and Bonora, E. ( 2010) Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N. Engl. J. Med. 363, 1341-1350.
13. Postic, C. and Girard J. ( 2008) The role of the lipogenic pathway in the development of hepatic steatosis. Diabetes. Metab. 34, 643-648.
14. Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., and Parks, E. J. ( 2005) Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 115, 1343-1351.
15. Nehra, V., Angulo, P., Buchman, A. L., and Lindor, K. D. ( 2001) Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis. Dig. Dis. Sci. 46, 2347-2352.
16. Diraison, F., Moulin, P., and Beylot, M. ( 2003) Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease. Diabetes Metab. 29, 478-485.
17. Rigazio, S., Lehto, H. R., Tuunanen, H., Nagren, K., Kankaanpaa, M., Simi, C., Borra, R., Naum, A. G., Parkkola, R., Knuuti, J., Nuutila, P., and Iozzo P. ( 2008) The lowering of hepatic fatty acid uptake improves liver function and insulin sensitivity without affecting hepatic fat content in humans. Am. J. Physiol. Endocrinol. Metab. 295, E413-E419.
18. Puri, P., Baillie, R. A., Wiest, M. M., Mirshahi, F., Choudhury, J., Cheung, O., Sargeant, C., Contos, M. J., and Sanyal, A. J. ( 2007) A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology 46, 1081-1090.
19. Listenberger, L. L., Han, X., Lewis, S. E., Cases, S., Farese, R. V., Jr., Ory, D. S., and Schaffer, J. E. ( 2003) Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc. Natl. Acad. Sci. USA 100, 3077-3082.
20. Yamaguchi, K., Yang, L., McCall, S., Huang, J., Yu, X. X., Pandey, S. K., Bhanot, S., Monia, B. P., Li, Y. X., and Diehl, A. M. ( 2007) Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology 45, 1366-1374.
21. Li, Z. Z., Berk, M., McIntyre, T. M., and Feldstein, A. E. ( 2009) Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase. J. Biol. Chem. 284, 5637-5644.
22. Malhi, H., Bronk, S. F., Werneburg, N. W., and Gores, G. J. ( 2006) Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis. J. Biol. Chem. 281, 12093-12101.
23. Wei, Y., Wang, D., Topczewski, F., and Pagliassotti, M. J. ( 2006) Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. Am. J. Physiol. Endocrinol. Metab. 291, E275-E281.
24. Wang, D., Wei, Y., Schmoll, D., Maclean, K. N., and Pagliassotti, M. J. ( 2006) Endoplasmic reticulum stress increases glucose-6-phosphatase and glucose cycling in liver cells. Endocrinology 147, 350-358.
25. Wei, Y., Wang, D., and Pagliassotti, M. J. ( 2007) Saturated fatty acid-mediated endoplasmic reticulum stress and apoptosis are augmented by trans-10, cis-12-conjugated linoleic acid in liver cells. Mol. Cell Biochem. 303, 105-113.
26. Zhang, K. and Kaufman, R. J. ( 2006) Protein folding in the endoplasmic reticulum and the unfolded protein response. Handb. Exp. Pharmacol. 172, 69-91.
27. Malhotra, J. D. and Kaufman, R. J. ( 2007) The endoplasmic reticulum and the unfolded protein response. Semin. Cell Dev. Biol. 18, 716-731.
28. Xu, C., Bailly-Maitre, B., and Reed, J. C. ( 2005) Endoplasmic reticulum stress: cell life and death decisions. J. Clin. Invest. 115, 2656-2664.
29. Wu, J. and Kaufman, R. J. ( 2006) From acute ER stress to physiological roles of the unfolded protein response. Cell Death Differ. 13, 374-384.
30. Zhang, K. and Kaufman, R. J. ( 2006) The unfolded protein response: a stress signaling pathway critical for health and disease. Neurology 66, S102-S109.
31. Hong, M., Luo, S., Baumeister, P., Huang, J. M., Gogia, R. K., Li, M., and Lee, A. S. ( 2004) Underglycosylation of ATF6 as a novel sensing mechanism for activation of the unfolded protein response. J. Biol. Chem. 279, 11354-11363.
32. Thuerauf, D. J., Morrison, L., and Glembotski, C. C. ( 2004) Opposing roles for ATF6alpha and ATF6beta in endoplasmic reticulum stress response gene induction. J. Biol. Chem. 279, 21078-21084.
33. Back, S. H., Schroder, M., Lee, K., Zhang, K., and Kaufman, R. J. ( 2005) ER stress signaling by regulated splicing: IRE1/HAC1/XBP1. Methods 35, 395-416.
34. Shen, J. and Prywes, R. ( 2005) ER stress signaling by regulated proteolysis of ATF6. Methods 35, 382-389.
35. Kim, I., Xu, W. and Reed, J. C. ( 2008) Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat. Rev. Drug Discov. 7, 1013-1030.
36. Hotamisligil, G. S. ( 2010) Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140, 900-917.
37. Rasheva, V. I. and Domingos, P. M. ( 2009) Cellular responses to endoplasmic reticulum stress and apoptosis. Apoptosis 14, 996-1007.
38. Zhang, K. and Kaufman, R. J. ( 2008) From endoplasmic-reticulum stress to the inflammatory response. Nature 454, 455-462.
39. Ozcan, U., Cao, Q., Yilmaz, E., Lee, A. H., Iwakoshi, N. N., Ozdelen, E., Tuncman, G., Gorgun, C., Glimcher, L. H., and Hotamisligil, G. S. ( 2004) Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306, 457-461.
40. Ozcan, U., Yilmaz, E., Ozcan, L., Furuhashi, M., Vaillancourt, E., Smith, R. O., Gorgun, C. Z., and Hotamisligil, G. S. ( 2006) Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 313, 1137-1140.
41. Lee, A. H., Scapa, E. F., Cohen, D. E., and Glimcher, L. H. ( 2008) Regulation of hepatic lipogenesis by the transcription factor XBP1. Science 320, 1492-1496.
42. Oyadomari, S., Harding, H. P., Zhang, Y., Oyadomari, M., and Ron, D. ( 2008) Dephosphorylation of translation initiation factor 2alpha enhances glucose tolerance and attenuates hepatosteatosis in mice. Cell Metab. 7, 520-532.
43. Rutkowski, D. T., Wu, J., Back, S. H., Callaghan, M. U., Ferris, S. P., Iqbal, J., Clark, R., Miao, H., Hassler, J. R., Fornek, J., Katze, M. G., Hussain, M. M., Song, B., Swathirajan, J., Wang, J., Yau, G. D., and Kaufman, R. J. ( 2008) UPR pathways combine to prevent hepatic steatosis caused by ER stress-mediated suppression of transcriptional master regulators. Dev. Cell 15, 829-840.
44. Kammoun, H. L., Chabanon, H., Hainault, I., Luquet, S., Magnan, C., Koike, T., Ferre, P., and Foufelle, F. ( 2009) GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice. J. Clin. Invest. 119, 1201-1215.
45. Marchetti, P., Bugliani, M., Lupi, R., Marselli, L., Masini, M., Boggi, U., Filipponi, F., Weir, G. C., Eizirik, D. L., and Cnop, M. ( 2007) The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients. Diabetologia 50, 2486-2494.
46. Boden, G., Duan, X., Homko, C., Molina, E. J., Song, W., Perez, O., Cheung, P., and Merali, S. ( 2008) Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals. Diabetes 57, 2438-2444.
47. Puri, P., Mirshahi, F., Cheung, O., Natarajan, R., Maher, J. W., Kellum, J. M., and Sanyal, A. J. ( 2008) Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease. Gastroenterology 134, 568-576.
48. Sharma, N. K., Das, S. K., Mondal, A. K., Hackney, O. G., Chu, W. S., Kern, P. A., Rasouli, N., Spencer, H. J., Yao-Borengasser, A., and Elbein, S. C. ( 2008) Endoplasmic reticulum stress markers are associated with obesity in nondiabetic subjects. J. Clin. Endocrinol. Metab. 93, 4532-4541.
49. Wang, D., Wei, Y., and Pagliassotti, M. J. ( 2006) Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis. Endocrinology 147, 943-951.
50. Pagliassotti, M. J., Wei, Y., and Wang, D. ( 2007) Insulin protects liver cells from saturated fatty acid-induced apoptosis via inhibition of c-Jun NH2 terminal kinase activity. Endocrinology 148, 3338-3345.
51. Rahman, S. M., Qadri, I., Janssen, R. C., and Friedman, J. E. ( 2009) Fenofibrate and PBA prevent fatty acid-induced loss of adiponectin receptor and pAMPK in human hepatoma cells and in hepatitis C virus-induced steatosis. J. Lipid Res. 50, 2193-2202.
52. Wei, Y., Wang, D., Gentile, C. L., and Pagliassotti, M. J. ( 2009) Reduced endoplasmic reticulum luminal calcium links saturated fatty acid-mediated endoplasmic reticulum stress and cell death in liver cells. Mol. Cell Biochem. 331, 31-40.
53. Akazawa, Y., Cazanave, S., Mott, J. L., Elmi, N., Bronk, S. F., Kohno, S., Charlton, M. R., and Gores, G. J. ( 2010) Palmitoleate attenuates palmitate-induced Bim and PUMA up-regulation and hepatocyte lipoapoptosis. J. Hepatol. 52, 586-593.
54. Pfaffenbach, K. T., Gentile, C. L., Nivala, A. M., Wang, D., Wei, Y., and Pagliassotti, M. J. ( 2010) Linking endoplasmic reticulum stress to cell death in hepatocytes: roles of C/EBP homologous protein and chemical chaperones in palmitate-mediated cell death. Am. J. Physiol. Endocrinol. Metab. 298, E1027-1035.
55. Turner, M. D. ( 2004) Fatty acyl CoA-mediated inhibition of endoplasmic reticulum assembly. Biochim. Biophys. Acta 1693, 1-4.
56. Moffitt, J. H., Fielding, B. A., Evershed, R., Berstan, R., Currie, J. M., and Clark, A. ( 2005) Adverse physicochemical properties of tripalmitin in beta cells lead to morphological changes and lipotoxicity in vitro. Diabetologia 48, 1819-1829.
57. Borradaile, N. M., Han, X., Harp, J. D., Gale, S. E., Ory, D. S., and Schaffer, J. E. ( 2006) Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death. J. Lipid Res. 47, 2726-2737.
58. Burdakov, D., Petersen, O. H., and Verkhratsky, A. ( 2005) Intraluminal calcium as a primary regulator of endoplasmic reticulum function. Cell Calcium 38, 303-310.
59. Gorlach, A., Klappa, P., and Kietzmann, T. ( 2006) The endoplasmic reticulum: folding, calcium homeostasis, signaling, and redox control. Antioxid. Redox Signal 8, 1391-1418.
60. Gwiazda, K. S., Yang, T. L., Lin, Y., and Johnson, J. D. ( 2009) Effects of palmitate on ER and cytosolic Ca2+ homeostasis in beta-cells. Am. J. Physiol. Endocrinol. Metab. 296, E690-E701.
61. Hirosumi, J., Tuncman, G., Chang, L., Gorgun, C. Z., Uysal, K. T., Maeda, K., Karin, M., and Hotamisligil, G. S. ( 2002) A central role for JNK in obesity and insulin resistance. Nature 420, 333-336.
62. Bogoyevitch, M. A., Boehm, I., Oakley, A., Ketterman, A. J., and Barr, R. K. ( 2004) Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential. Biochim. Biophys. Acta 1697, 89-101.
63. Schattenberg, J. M., Singh, R., Wang, Y., Lefkowitch, J. H., Rigoli, R. M., Scherer, P. E., and Czaja, M. J. ( 2006) JNK1 but not JNK2 promotes the development of steatohepatitis in mice. Hepatology 43, 163-172.
64. Kodama, Y., Kisseleva, T., Iwaisako, K., Miura, K., Taura, K., De Minicis, S., Osterreicher, C. H., Schnabl, B., Seki, E., and Brenner, D. A. ( 2009) c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice. Gastroenterology 137, 1467-1477 e1465.
65. Singh, R., Wang, Y., Xiang, Y., Tanaka, K. E., Gaarde, W. A., and Czaja, M. J. ( 2009) Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance. Hepatology 49, 87-96.
66. Davis, R. J. ( 2000) Signal transduction by the JNK group of MAP kinases. Cell 103, 239-252.
67. Srivastava, R. K., Sollott, S. J., Khan, L., Hansford, R., Lakatta, E. G., and Longo, D. L. ( 1999) Bcl-2 and Bcl-X(L) block thapsigargin-induced nitric oxide generation, c-Jun NH(2)-terminal kinase activity, and apoptosis. Mol. Cell Biol. 19, 5659-5674.
68. Urano, F., Wang, X., Bertolotti, A., Zhang, Y., Chung, P., Harding, H. P., and Ron, D. ( 2000) Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 287, 664-666.
69. Cazanave, S. C., Mott, J. L., Elmi, N. A., Bronk, S. F., Werneburg, N. W., Akazawa, Y., Kahraman, A., Garrison, S. P., Zambetti, G. P., Charlton, M. R., and Gores, G. J. ( 2009) JNK1-dependent PUMA expression contributes to hepatocyte lipoapoptosis. J. Biol. Chem. 284, 26591-26602.
70. Nakamura, S., Takamura, T., Matsuzawa-Nagata, N., Takayama, H., Misu, H., Noda, H., Nabemoto, S., Kurita, S., Ota, T., Ando, H., Miyamoto, K., and Kaneko, S. ( 2009) Palmitate induces insulin resistance in H4IIEC3 hepatocytes through reactive oxygen species produced by mitochondria. J. Biol. Chem. 284, 14809-14818.
71. Ribeiro, P. S., Cortez-Pinto, H., Sola, S., Castro, R. E., Ramalho, R. M., Baptista, A., Moura, M. C., Camilo, M. E., and Rodrigues, C. M. ( 2004) Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients. Am. J. Gastroenterol. 99, 1708-1717.
72. Videla, L. A., Tapia, G., Rodrigo, R., Pettinelli, P., Haim, D., Santibanez, C., Araya, V. A., Smok, G., Csendes, A., Gutierrez, L., Rojas, J., Castillo, J., Korn, O., Maluenda, F., Diaz, J. C., Rencoret, G., and Poniachik, J. ( 2009) Liver NF-kappaB and AP-1 DNA binding in obese patients. Obesity (Silver Spring) 17, 973-979.
73. Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., and Shoelson, S. E. ( 2005) Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat. Med. 11, 183-190.
74. Dela Pena, A., Leclercq, I., Field, J., George, J., Jones, B., and Farrell, G. ( 2005) NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis. Gastroenterology 129, 1663-1674.
75. Iimuro, Y., Nishiura, T., Hellerbrand, C., Behrns, K. E., Schoonhoven, R., Grisham, J. W., and Brenner, D. A. ( 1998) NFkappaB prevents apoptosis and liver dysfunction during liver regeneration. J. Clin. Invest. 101, 802-811.
76. Novak, T. E., Babcock, T. A., Jho, D. H., Helton, W. S., and Espat, N. J. ( 2003) NF-kappa B inhibition by omega -3 fatty acids modulates LPS-stimulated macrophage TNF-alpha transcription. Am. J. Physiol. Lung Cell Mol. Physiol. 284, L84-89.
77. Senn, J. J. ( 2006) Toll-like receptor-2 is essential for the development of palmitate-induced insulin resistance in myotubes. J. Biol. Chem. 281, 26865-26875.
78. Pahl, H. L. and Baeuerle, P. A. ( 1995) A novel signal transduction pathway from the endoplasmic reticulum to the nucleus is mediated by transcription factor NF-kappa B. EMBO J 14, 2580-2588.
79. Pahl, H. L. and Baeuerle, P. A. ( 1996) Activation of NF-kappa B by ER stress requires both Ca2+ and reactive oxygen intermediates as messengers. FEBS Lett 392, 129-136.
80. Hung, J. H., Su, I. J., Lei, H. Y., Wang, H. C., Lin, W. C., Chang, W. T., Huang, W., Chang, W. C., Chang, Y. S., Chen, C. C., and Lai, M. D. ( 2004) Endoplasmic reticulum stress stimulates the expression of cyclooxygenase-2 through activation of NF-kappaB and pp38 mitogen-activated protein kinase. J. Biol. Chem. 279, 46384-46392.
81. Deng, J., Lu, P. D., Zhang, Y., Scheuner, D., Kaufman, R. J., Sonenberg, N., Harding, H. P., and Ron, D. ( 2004) Translational repression mediates activation of nuclear factor kappa B by phosphorylated translation initiation factor 2. Mol. Cell. Biol. 24, 10161-10168.
82. Yamazaki, H., Hiramatsu, N., Hayakawa, K., Tagawa, Y., Okamura, M., Ogata, R., Huang, T., Nakajima, S., Yao, J., Paton, A. W., Paton, J. C., and Kitamura, M. ( 2009) Activation of the Akt-NF-kappaB pathway by subtilase cytotoxin through the ATF6 branch of the unfolded protein response. J. Immunol. 183, 1480-1487.
83. Jiang, H. Y., Wek, S. A., McGrath, B. C., Scheuner, D., Kaufman, R. J., Cavener, D. R., and Wek, R. C. ( 2003) Phosphorylation of the alpha subunit of eukaryotic initiation factor 2 is required for activation of NF-kappaB in response to diverse cellular stresses. Mol. Cell. Biol. 23, 5651-5663.
84. Wu, S., Tan, M., Hu, Y., Wang, J. L., Scheuner, D., and Kaufman, R. J. ( 2004) Ultraviolet light activates NFkappaB through translational inhibition of IkappaBalpha synthesis. J. Biol. Chem. 279, 34898-34902.
85. Tonnesen, M. F., Grunnet, L. G., Friberg, J., Cardozo, A. K., Billestrup, N., Eizirik, D. L., Storling, J., and Mandrup-Poulsen, T. ( 2009) Inhibition of nuclear factor-kappaB or Bax prevents endoplasmic reticulum stress-but not nitric oxide-mediated apoptosis in INS-1E cells. Endocrinology 150, 4094-4103.
86. Guicciardi, M. E., Bronk, S. F., Werneburg, N. W., Yin, X. M., and Gores, G. J. ( 2005) Bid is upstream of lysosome-mediated caspase 2 activation in tumor necrosis factor alpha-induced hepatocyte apoptosis. Gastroenterology 129, 269-284.
87. Carter-Kent, C., Zein, N. N., and Feldstein, A. E. ( 2008) Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment. Am. J. Gastroenterol. 103, 1036-1042.
88. Tilg, H. and Moschen, A. R. ( 2008) Insulin resistance, inflammation, and non-alcoholic fatty liver disease. Trends Endocrinol. Metab. 19, 371-379.
89. Crespo, J., Cayon, A., Fernandez-Gil, P., Hernandez-Guerra, M., Mayorga, M., Dominguez-Diez, A., Fernandez-Escalante, J. C., and Pons-Romero, F. ( 2001) Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology 34, 1158-1163.
90. Wigg, A. J., Roberts-Thomson, I. C., Dymock, R. B., McCarthy, P. J., Grose, R. H., and Cummins, A. G. ( 2001) The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut 48, 206-211.
91. Abiru, S., Migita, K., Maeda, Y., Daikoku, M., Ito, M., Ohata, K., Nagaoka, S., Matsumoto, T., Takii, Y., Kusumoto, K., Nakamura, M., Komori, A., Yano, K., Yatsuhashi, H., Eguchi, K., and Ishibashi, H. ( 2006) Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis. Liver Int. 26, 39-45.
92. Haukeland, J. W., Damas, J. K., Konopski, Z., Loberg, E. M., Haaland, T., Goverud, I., Torjesen, P. A., Birkeland, K., Bjoro, K., and Aukrust, P. ( 2006) Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. J. Hepatol. 44, 1167-1174.
93. Valenti, L., Fracanzani, A. L., Dongiovanni, P., Santorelli, G., Branchi, A., Taioli, E., Fiorelli, G., and Fargion, S. ( 2002) Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease. Gastroenterology 122, 274-280.
94. Tokushige, K., Takakura, M., Tsuchiya-Matsushita, N., Taniai, M., Hashimoto, E., and Shiratori, K. ( 2007) Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis. J. Hepatol. 46, 1104-1110.
95. Li, Z., Yang, S., Lin, H., Huang, J., Watkins, P. A., Moser, A. B., Desimone, C., Song, X. Y., and Diehl, A. M. ( 2003) Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 37, 343-350.
96. Tomita, K., Tamiya, G., Ando, S., Ohsumi, K., Chiyo, T., Mizutani, A., Kitamura, N., Toda, K., Kaneko, T., Horie, Y., Han, J. Y., Kato, S., Shimoda, M., Oike, Y., Tomizawa, M., Makino, S., Ohkura, T., Saito, H., Kumagai, N., Nagata, H., Ishii, H., and Hibi T. ( 2006) Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice. Gut 55, 415-424.
97. Adams, L. A., Zein, C. O., Angulo, P., and Lindor, K. D. ( 2004) A pilot trial of pentoxifylline in nonalcoholic steatohepatitis. Am. J. Gastroenterol. 99, 2365-2368.
98. Satapathy, S. K., Sakhuja, P., Malhotra, V., Sharma, B. C., and Sarin, S. K. ( 2007) Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis. J. Gastroenterol. Hepatol. 22, 634-638.
99. Feldstein, A. E., Werneburg, N. W., Canbay, A., Guicciardi, M. E., Bronk, S. F., Rydzewski, R., Burgart, L. J., and Gores, G. J. ( 2004) Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology 40, 185-194.
100. Omori, Y., Imai, J., Watanabe, M., Komatsu, T., Suzuki, Y., Kataoka, K., Watanabe, S., Tanigami, A., and Sugano, S. ( 2001) CREB-H: a novel mammalian transcription factor belonging to the CREB/ATF family and functioning via the box-B element with a liver-specific expression. Nucleic Acids Res. 29, 2154-2162.
101. Zhang, K., Shen, X., Wu, J., Sakaki, K., Saunders, T., Rutkowski, D. T., Back, S. H., and Kaufman, R. J. ( 2006) Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response. Cell 124, 587-599.
102. Luebke-Wheeler, J., Zhang, K., Battle, M., K. Si-Tayeb, W. Garrison, S. Chhinder, J. Li, Kaufman, R. J., and Duncan, S. A. ( 2008) Hepatocyte nuclear factor 4alpha is implicated in endoplasmic reticulum stress-induced acute phase response by regulating expression of cyclic adenosine monophosphate responsive element binding protein H. Hepatology 48, 1242-1250.
103. Danno, H., Ishii, K. A., Nakagawa, Y., Mikami, M., Yamamoto, T., Yabe, S., Furusawa, M., Kumadaki, S., Watanabe, K., Shimizu, H., Matsuzaka, T., Kobayashi, K., Takahashi, A., Yatoh, S., Suzuki, H., Yamada, N., and Shimano, H. ( 2009) The liver-enriched transcription factor CREBH is nutritionally regulated and activated by fatty acids and PPARalpha. Biochem. Biophys. Res. Commun. 391, 1222-1227.
104. Gentile, C. L., Wang, D., Pfaffenbach, K. T., Cox, R., Wei, Y., and Pagliassotti, M. J. ( 2010) Fatty acids regulate CREBh via transcriptional mechanisms that are dependent on proteasome activity and insulin. Mol. Cell. Biochem. 344, 99-107.
105. Listenberger, L. L., Ory, D. S., and Schaffer, J. E. ( 2001) Palmitate-induced apoptosis can occur through a ceramide-independent pathway. J. Biol. Chem 276, 14890-14895.
106. Chalasani, N., Deeg, M. A., and Crabb, D. W. ( 2004) Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis. Am. J. Gastroenterol. 99, 1497-1502.
107. Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., and Shimomura, I. ( 2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 114, 1752-1761.
108. Videla, L. A., Rodrigo, R., Orellana, M., Fernandez, V., Tapia, G., Quinones, L., Varela, N., Contreras, J., Lazarte, R., Csendes, A., Rojas, J., Maluenda, F., Burdiles, P., Diaz, J. C., Smok, G., Thielemann, L., and Poniachik, J. ( 2004) Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. Clin. Sci. (Lond) 106, 261-268.
109. Narasimhan, S., Gokulakrishna, K., Sampathkumar, R., Farooq, S., Ravikumar, R., Mohan, V., and Balasubramany, M. ( 2010) Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes. Clin. Biochem. 43, 815-821.
110. Tu, B. P. and Weissman, J. S. ( 2004) Oxidative protein folding in eukaryotes: mechanisms and consequences. J. Cell Biol. 164, 341-346.
111. Chakravarthi, S., Jessop, C. E., and Bulleid, N. J. ( 2006) The role of glutathione in disulphide bond formation and endoplasmic-reticulum-generated oxidative stress. EMBO Rep. 7, 271-275.
112. Malhotra, J. D. and Kaufman, R. J. ( 2007) Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword? Antioxid. Redox Signal 9, 2277-2293.
113. Shimizu, Y. and Hendershot, L. M. ( 2009) Oxidative folding: cellular strategies for dealing with the resultant equimolar production of reactive oxygen species. Antioxid. Redox Signal 11, 2317-2331.
114. Malhotra, J. D., Miao, H., Zhang, K., Wolfson, A., Pennathur, S., Pipe, S. W., and Kaufman, R. J. ( 2008) Antioxidants reduce endoplasmic reticulum stress and improve protein secretion. Proc. Natl. Acad. Sci. USA 105, 18525-18530.
115. Oyadomari, S. and Mori, M. ( 2004) Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ. 11, 381-389.
116. Ma, Y., Brewer, J. W., Diehl, J. A., and Hendershot, L. M. ( 2002) Two distinct stress signaling pathways converge upon the CHOP promoter during the mammalian unfolded protein response. J. Mol. Biol. 318, 1351-1365.
117. Wu, J., Rutkowski, D. T., Dubois, M., Swathirajan, J., Saunders, T., Wang, J., Song, B., Yau, G. D., and Kaufman, R. J. ( 2007) ATF6alpha optimizes long-term endoplasmic reticulum function to protect cells from chronic stress. Dev. Cell 13, 351-364.
118. Cullinan, S. B., Zhang, D., Hannink, M., Arvisais, E., Kaufman, R. J., and Diehl, J. A. ( 2003) Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival. Mol. Cell Biol. 23, 7198-7209.
119. Nguyen, T., Nioi, P., and Pickett, C. B. ( 2009) The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J. Biol. Chem. 284, 13291-13295.
120. Sugimoto, H., Okada, K., Shoda, J., Warabi, E., Ishige, K., Ueda, T., Taguchi, K., Yanagawa, T., Nakahara, A., Hyodo, I., Ishii, T., and Yamamoto, M. ( 2010) Deletion of nuclear factor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 298, G283-G294.
121. Back, S. H., Scheuner, D., Han, J., Song, B., Ribick, M., Wang, J., Gildersleeve, R. D., Pennathur, S., and Kaufman, R. J. ( 2009) Translation attenuation through eIF2alpha phosphorylation prevents oxidative stress and maintains the differentiated state in beta cells. Cell Metab. 10, 13-26.
122. Liu, Y., Adachi, M., Zhao, S., Hareyama, M., Koong, A. C., Luo, D., Rando, T. A., Imai, K., and Shinomura, Y. ( 2009) Preventing oxidative stress: a new role for XBP1. Cell Death Differ. 16, 847-857.
123. Wei, M. C., Zong, W. X., Cheng, E. H., Lindsten, T., Panoutsakopou, V., lou, Ross, A. J., Roth, K. A., MacGregor, G. R., Thompson, C. B., and Korsmeyer, S. J. ( 2001) Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292, 727-730.
124. Kuwana, T., Mackey, M. R., Perkins, G., Ellisman, M. H., Latterich, M., Schneiter, R., Green, D. R., and Newmeyer, D. D. ( 2002) Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 111, 331-342.
125. Feldstein, A. E., Canbay, A., Angulo, P., Taniai, M., Burgart, L. J., Lindor, K. D., and Gores, G. J. ( 2003) Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 125, 437-443.
126. Papatheodorid, G. V., is. Hadziyannis, E., Tsochatzis, E., Georgiou, A., Kafiri, G., Tiniakos, D. G., Margariti, K., Manolakopoulo, S., s, Manesis, E. K., and Archimandriti, A. J. ( 2010) Serum apoptotic caspase activity in chronic hepatitis C and nonalcoholic Fatty liver disease. J. Clin. Gastroenterol. 44, e87-e95.
127. Witek, R. P., Stone, W. C., Karaca, F. G., Syn, W. K., Pereira, T. A., Agboola, K. M., Omenetti, A., Jung, Y., Teaberry, V., Choi, S. S., Guy, C. D., Pollard, J., Charlton, P., and Diehl, A. M. ( 2009) Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis. Hepatology 50, 1421-1430.
128. Zinszner, H., Kuroda, M., Wang, X., Batchvarova, N., Lightfoot, R. T., Remotti, H., Stevens, J. L., and Ron, D. ( 1998) CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev. 12, 982-995.
129. Ji, C., Mehrian-Shai, R., Chan, C., Hsu, Y. H., and Kaplowitz N. ( 2005) Role of CHOP in hepatic apoptosis in the murine model of intragastric ethanol feeding. Alcohol Clin. Exp. Res. 29, 1496-1503.
130. Tamaki, N., Hatano, E., Taura, K., Tada, M., Kodama, Y., Nitta, T., Iwaisako, K., Seo, S., Nakajima, A., Ikai, I., and Uemoto, S. ( 2008) CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury. Am. J. Physiol. Gastrointest. Liver Physiol. 294, G498-505.
131. Cunha, D. A., Hekerman, P., Ladriere, L., Bazarra-Castro, A., Ortis, F., Wakeham, M. C., Moore, F., Rasschaert, J., Cardozo, A. K., Bellomo, E., Overbergh, L., Mathieu, C., Lupi, R., Hai, T., Herchuelz, A., Marchetti, P., Rutter, G. A., Eizirik, D. L., and Cnop, M. ( 2008) Initiation and execution of lipotoxic ER stress in pancreatic beta-cells. J. Cell Sci. 121, 2308-2318.
132. Cazanave, S. C., Elmi, N. A., Akazawa, Y., Bronk, S. F., Mott, J. L., and Gores, G. J. ( 2010) CHOP and AP-1 cooperatively mediate PUMA expression during lipoapoptosis. Am. J. Physiol. Gastrointest. Liver Physiol. 299, G236-G243.
133. Sambrook, J. F. ( 1990) The involvement of calcium in transport of secretory proteins from the endoplasmic reticulum. Cell 61, 197-199.
134. Rapoport, T. A. ( 1992) Transport of proteins across the endoplasmic reticulum membrane. Science 258, 931-936.
135. Pinton, P., Giorgi, C., Siviero, R., Zecchini, E., an Rizzuto, R. ( 2008) Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis. Oncogene 27, 6407-6418.
136. Zhou, Y. P., Teng, D., Dralyuk, F., Ostrega, D., Roe, M. W., Philipson, L., and Polonsky, K. S. ( 1998) Apoptosis in insulin-secreting cells. Evidence for the role of intracellular Ca2+ stores and arachidonic acid metabolism. J. Clin. Invest. 101, 1623-1632.
137. Luciani, D. S., Gwiazda, K. S., Yang, T. L., Kalynyak, T. B., Bychkivska, Y., Frey, M. H., Jeffrey, K. D., Sampaio, A. V., Underhill, T. M., and Johnson, J. D. ( 2009) Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. Diabetes 58, 422-432.
138. McCullough, K. D., Martindale, J. L., Klotz, L. O., Aw, T. Y., and Holbrook, N. J. ( 2001) Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state. Mol. Cell Biol. 21, 1249-1259.
139. Puthalakath, H., O, L. A., 'Reilly, Gunn, P., Lee, L., Kelly, P. N., Huntington, N. D., Hughes, P. D., Michalak, E. M., McKimm-Breschkin, J., Motoyama, N., Gotoh, T., Akira, S., Bouillet, P., and Strasser, A. ( 2007) ER stress triggers apoptosis by activating BH3-only protein Bim. Cell 129, 1337-1349.
140. Szegezdi, E., Macdonald, D. C., T. Ni Chonghaile, Gupta, S., and Samali, A. ( 2009) Bcl-2 family on guard at the ER. Am. J. Physiol. Cell Physiol. 296, C941-953.
141. Chipuk, J. E., Moldoveanu, T., Llambi, F., Parsons, M. J., and Green, D. R. ( 2010) The BCL-2 family reunion. Mol. Cell 37, 299-310.
142. Panasiuk, A., Dzieciol, J., Panasiuk, B., and Prokopowicz, D. ( 2006) Expression of p53, Bax and Bcl-2 proteins in hepatocytes in non-alcoholic fatty liver disease. World J. Gastroenterol. 12, 6198-6202.
143. Barreyro, F. J., Kobayashi, S., Bronk, S. F., Werneburg, N. W., Malhi, H., and Gores, G. J. ( 2007) Transcriptional regulation of Bim by FoxO3A mediates hepatocyte lipoapoptosis. J. Biol. Chem. 282, 27141- 27154.
144. Klee, M. and Pimentel-Muinos, F. X. ( 2005) Bcl-X(L) specifically activates Bak to induce swelling and restructuring of the endoplasmic reticulum. J Cell. Biol. 168, 723-734.
145. Bailly-Maitre, B., Fondevila, C., Kaldas, F., Droin, N., Luciano, F., Ricci, J. E., Croxton, R., Krajewska, M., Zapata, J. M., Kupiec-Weglinski, J. W., Farmer, D., and Reed, J. C. ( 2006) Cytoprotective gene bi-1 is required for intrinsic protection from endoplasmic reticulum stress and ischemia-reperfusion injury. Proc. Natl. Acad. Sci. USA 103, 2809-2814.
146. Hetz, C., Bernasconi, P., Fisher, J., Lee, A. H., Bassik, M. C., Antonsson, B., Brandt, G. S., Iwakoshi, N. N., Schinzel, A., Glimcher, L. H., and Korsmeyer, S. J. ( 2006) Proapoptotic BAX and BAK modulate the unfolded protein response by a direct interaction with IRE1alpha. Science 312, 572-576.
147. Lisbona, F., Rojas-Rivera, D., Thielen, P., Zamorano, S., Todd, D., Martinon, F., Glavic, A., Kress, C., Lin, J. H., Walter, P., Reed, J. C., Glimcher, L. H., and Hetz, C. ( 2009) BAX inhibitor-1 is a negative regulator of the ER stress sensor IRE1alpha. Mol. Cell 33, 679-691.
148. Bailly-Maitre, B., Belgardt, B. F., Jordan, S. D., Coornaert, B., von, M. J., Freyend, Kleinridders, A., Mauer, J., Cuddy, M., Kress, C. L., Willmes, D., Essig, M., Hampel, B., Protzer, U., Reed, J. C., and Bruning, J. C. ( 2010) Hepatic Bax inhibitor-1 inhibits IRE1alpha and protects from obesity-associated insulin resistance and glucose intolerance. J. Biol. Chem. 285, 6198-6207.
149. Scorrano, L., Oakes, S. A., Opferman, J. T., Cheng, E. H., Sorcinelli, M. D., Pozzan, T., and Korsmeyer, S. J. ( 2003) BAX and BAK regulation of endoplasmic reticulum Ca2+: a control point for apoptosis. Science 300, 135-139.
150. Palmer, A. E., Jin, C., Reed, J. C., and Tsien, R. Y. ( 2004) Bcl-2-mediated alterations in endoplasmic reticulum Ca2+ analyzed with an improved genetically encoded fluorescent sensor. Proc Natl Acad Sci USA 101, 17404-17409.
151. Oakes, S. A., Scorrano, L., Opferman, J. T., Bassik, M. C., Nishino, M., Pozzan, T., and Korsmeyer, S. J. ( 2005) Proapoptotic BAX and BAK regulate the type 1 inositol trisphosphate receptor and calcium leak from the endoplasmic reticulum. Proc. Natl. Acad. Sci. USA 102, 105-110.